According to Alembic Pharmaceuticals's latest financial reports the company's current earnings are HK$0.74 Billion. In 2023 the company made an earning of HK$0.58 Billion, an increase over its 2022 earnings that were of HK$0.30 Billion. The earnings displayed on this page is the company's Pretax Income.